VB Spine Appoints Thomas E. Oglesby as New Chief Financial Officer

In his new role, Oglesby will lead VB Spine's finance organization and partner with the executive team on strategy, capital allocation, and continued growth of the company's spine portfolio.
Seeking Alpha

VO + VB Vs. VXF: Picking The Better ETF Strategy

Owning the VO ETF and VB ETF in weights that best suits the investor and comparing those results against owning the VXF ETF, where the investor doesn't control the allocation between Mid-Cap and Small ...
Seeking Alpha

VB: I Was Bullish On Small Caps A Year Ago, And I Still Am Today

The purpose of this article is to evaluate the Vanguard Small-Cap Index Fund ETF (NYSEARCA:VB) as an investment at the current market price. This fund's objective is "to track the performance of the ...
Rutland Herald

VB Spine Announces FDA Breakthrough Device Designation for New Blood Test Designed to Identify Patients at Risk for Scoliosis Progression

VB Spine LLC (“VB Spine”), the largest privately -held spine company, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to ScolimiR-3D, an in ...
The Manila Times

VB Health Launches Public Seven-Part Supplement Quality Standard

New company-wide standard, effective across the VB Health portfolio, establishes requirements for research, clinically relevant dosing, formula transparency, sourcing, U.S. manufacturing and every-bat ...
Visual Studio Magazine

VB.NET Popularity Still Rising

Visual Basic.NET is getting comfortable in its new position as a top five programming language in the TIOBE index, which measures popularity based on search engine data. After hitting a high in the ...